12 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

iQ200 Series

FDA 510(k)
FDA Class 2 ·Hematology

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776382520·10mm, 33cm Laparoscopic Clip Applicator for sma...

Disposable Surgical Mask

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

rescuenet

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

HA TAPERLOC POR FMRL 7.5X135

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code MEH·June 1, 2020

SHELL WITH CLUSTER HOLES POROUS 46 MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code LPH·June 1, 2020

OT VERIO2 METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·November 15, 2014

IVT DISPOSABLE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - MALTA·Product code KPE·September 18, 2011

ALARIS EXTENSION SET

FDA Adverse Event
Malfunction ·CAREFUSION CORP·Product code FPA·July 15, 2013

28MM DIA COCR MOD HD -6MM NK

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code JDI·June 1, 2020

LINER NEUTRAL 28 MM I.D. SIZE FF FOR USE WITH 46 MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code LPH·June 1, 2020

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014